We have elucidated an emerging functionality of SPHK1, identified SPHK1-mediated immunosuppression established by transcriptional regulation of PD-L1 in malignant melanoma and demonstrated a novel mechanism of PD-L1 expression. Here, SPHK1 is linked to melanoma.